Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) on Friday, soared 11.19% from the previous trading day, before settling in for the closing price of $44.72. Within the past 52 weeks, TNXP’s price has moved between $6.76 and $130.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 73.03% over the last five years. The company achieved an average annual earnings per share of 93.08%. With a float of $7.35 million, this company’s outstanding shares have now reached $7.36 million.
The firm has a total of 81 workers. Let’s measure their productivity. In terms of profitability, gross margin is 29.81%, operating margin of -721.51%, and the pretax margin is -1146.27%.
Tonix Pharmaceuticals Holding Corp (TNXP) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Tonix Pharmaceuticals Holding Corp is 0.07%, while institutional ownership is 6.64%. The most recent insider transaction that took place on May 15 ’25, was worth 86,200. In this transaction Chief Executive Officer of this company bought 4,000 shares at a rate of $21.55, taking the stock ownership to the 4,005 shares.
Tonix Pharmaceuticals Holding Corp (TNXP) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 93.08% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 88.07% during the next five years compared to 73.03% growth over the previous five years of trading.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Trading Performance Indicators
Tonix Pharmaceuticals Holding Corp (TNXP) is currently performing well based on its current performance indicators. A quick ratio of 11.64 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 36.44.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2930.78, a number that is poised to hit -5.18 in the next quarter and is forecasted to reach -6.08 in one year’s time.
Technical Analysis of Tonix Pharmaceuticals Holding Corp (TNXP)
Analysing the last 5-days average volume posted by the [Tonix Pharmaceuticals Holding Corp, TNXP], we can find that recorded value of 1.58 million was better than the volume posted last year of 1.29 million. As of the previous 9 days, the stock’s Stochastic %D was 63.61%.
During the past 100 days, Tonix Pharmaceuticals Holding Corp’s (TNXP) raw stochastic average was set at 98.45%, which indicates a significant increase from 95.84% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 3.70 in the past 14 days, which was higher than the 3.14 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $37.03, while its 200-day Moving Average is $24.37. Now, the first resistance to watch is $51.56. This is followed by the second major resistance level at $53.40. The third major resistance level sits at $56.93. If the price goes on to break the first support level at $46.20, it is likely to go to the next support level at $42.67. Now, if the price goes above the second support level, the third support stands at $40.83.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Key Stats
Market capitalization of the company is 365.84 million based on 7,357K outstanding shares. Right now, sales total 10,090 K and income totals -130,040 K. The company made 2,430 K in profit during its latest quarter, and -16,830 K in sales during its previous quarter.
